T cell subsets and cellular immunity in end-stage renal disease

Area of Science:

• Immunology
• Nephrology
• Cell Biology

Background:

• End-stage renal disease (ESRD) requiring long-term maintenance intermittent hemodialysis significantly impacts patient health.
• Understanding the effects of hemodialysis on the immune system is crucial for managing complications in ESRD patients.

Purpose of the Study:

• To investigate the T lymphocyte population and function in patients undergoing long-term hemodialysis.
• To assess the impact of hemodialysis duration and patient age on specific T cell subsets and their responsiveness.

Main Methods:

• Immunofluorescent staining with monoclonal antibodies and laser flow cytometry were used to analyze T lymphocyte populations.
• Blood samples from 50 end-stage renal disease patients on maintenance hemodialysis were analyzed.
• In vitro lymphocyte responses were evaluated using mixed lymphocyte reactions and phytohemagglutinin stimulation.

Main Results:

• Patients on hemodialysis for over one year exhibited lower absolute numbers of T cells and helper T cells.
• Age-dependent reductions in T cell subsets were observed: helper T cells were reduced in all age groups, while suppressor/cytotoxic T lymphocytes were reduced in those aged 30-60.
• In vitro lymphocyte proliferation assays showed reduced responses to both allogeneic stimulation (mixed lymphocyte reaction) and mitogenic stimulation (phytohemagglutinin).
• Natural killer cell cytotoxicity remained unaffected by long-term hemodialysis.

Conclusions:

• Long-term hemodialysis is associated with significant alterations in T lymphocyte populations, particularly a reduction in helper T cells.
• The observed T cell dysfunction may contribute to the compromised immune status of patients with end-stage renal disease.
• While NK cell function appears preserved, the impaired T cell response warrants further investigation and potential therapeutic considerations.